Discontinued Operations The summary of the assets and liabilities related to Pharmaceutical Manufacturing- China discontinued operations (Details) (USD $)				3 Months Ended	12 Months Ended
	Mar. 31, 2013	Dec. 31, 2012	Mar. 31, 2012	Mar. 31, 2012 Pharmaceutical Manufacturing - China business [Member]	Dec. 31, 2012 Pharmaceutical Manufacturing - China business [Member]	Nov. 13, 2012 Pharmaceutical Manufacturing - China business [Member]	Dec. 31, 2012 Equity Purchase Agreement [Member] CBH Acquisition LLC [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal Group, Including Discontinued Operation, Accrued Liabilities					$ (2,008,800)
Equity Method Investment, Ownership Percentage							51.00%
Available-for-sale Securities, Fair Value Disclosure					13,397,900
Noncontrolling interests	(420,724)	(356,970)			6,015,000
Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax					4,387,400
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents	0		14,766,629		8,457,500
Cash and cash equivalents	9,253,591	13,737,452	7,004,760			12,300,000
Restricted cash					2,918,100
Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net					6,130,200
Inventory					15,077,700
Prepaid expenses and other current assets					957,800
Property, plant and equipment, net					38,102,000
Other assets					5,946,300
Disposal Group, Including Discontinued Operation, Accounts Payable					9,604,800
Total assets		23,800,300
Bank loans					(15,133,500)
Notes payable					(6,599,300)
Unearned revenue					(9,166,800)
Amount due related parties					(7,859,700)
Total Liabilities					(27,216,700)
Loss on exit of segment				$ 0	$ (3,416,400)
Treasury Stock, Shares						1,040,000
Stock Option Cancelled						1,170,000
Warrants Cancelled						640,000